Unknown

Dataset Information

Anticoagulant Preferences and Concerns among Venous Thromboembolism Patients.


ABSTRACT:

Background

Warfarin and direct oral anticoagulants (DOACs) are used for the initial treatment and secondary prevention of venous thromboembolism (VTE), and have similar efficacy. Patient concerns and preferences are important considerations when selecting an anticoagulant, yet these are not well studied.

Methods

VTE patients (n = 519) were surveyed from online sources (clotconnect.org, stoptheclot.org and National Blood Clot Alliance Facebook followers [n = 495]) and a haematology clinic in Vermont (n = 24).

Results

Patients were 83% females and on average (±standard deviation [SD]) 45.7 ± 13.1 years; 65% self-reported warfarin as their initial VTE treatment and 35% a DOAC. Proportions reporting being extremely concerned about the following outcom

SUBMITTER: Lutsey PL 

PROVIDER: S-EPMC6203330 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature